Your private treatment suite is designed with clinical rigor and your emotional comfort in equal regard: cozy blankets, pillows, eye masks, art books and more.
We pair clinical rigor with genuine care: continuous monitoring, a comfortable medical environment, and a team focused on your safety and well-being throughout every session.

From your first call to your first session, our team guides you through each step. Two of them can happen side by side, so you're often not waiting on one to start the other. Tap a step to see what it involves, courtesy of a short intro from a Lumin Health leader.








The first month is the most frequent. Each dot is one visit of a little over two hours: a quick check-in, your treatment, then two hours of rest while our clinical team keeps an eye on you.
Typical Spravato course. Your care team sets your actual schedule, and IM ketamine schedules can differ.
Your first call is free, with our patient concierge team.
Book Free Consultation
.avif)






The questions our concierge team hears most.

Ketamine therapy feels different for everyone, but many describe it as entering a state of “spaciousness.” You may notice your inner critic quieting, emotions surfacing more gently, or memories appearing with less weight. Some patients report vivid imagery, dreamlike sensations, or simply a deep sense of calm. This dissociative state is not the goal itself but often serves as the gateway for emotional release and new perspectives.
Yes: when ketamine therapy is done with care, clarity, and clinical oversight, its safety profile is among the most favorable in psychiatric medicine, especially when used at therapeutic doses within a structured setting.
The ketamine safe dose range provides a strong foundation. But the real work of safety happens in how we prepare patients, how we stay present with them, and how we help them integrate what they’ve learned.
At Lumin Health, we believe that safety is not the absence of risk — it’s the presence of trust. And in the right hands, ketamine therapy can be not only safe, but profoundly transformative. We greatly encourage you to reach out to our team directly to discuss any specific concerns, as each individual case is complex and requires careful consideration.
Some people notice improvement within hours or days, while others experience gradual relief over 2–3 weeks. Signs that treatment may be working include shifts in mood, increased energy, or changes in how you relate to your thoughts and emotions. Clinicians often track these changes with structured rating scales like MADRS (used at Lumin Health) alongside your own reflections on daily life.
The hours and days after a session are a window when your brain is more flexible — a state called neuroplasticity. During this time, reflection, psychotherapy, journaling, or even simple practices like going for a mindful walk can help reinforce healthier patterns of thought. Many patients find that talking about their experiences with a trusted support system helps “lock in” the insights from treatment.
Yes — for many people, the change after ketamine therapy can be both real and rapid. Clinical studies and patient experiences consistently show that ketamine can ease symptoms of depression, sometimes within hours or days, even when years of traditional treatments have failed. Patients often describe a lifting of emotional heaviness, a renewed sense of perspective, and a greater ability to engage in therapy or daily life. While results vary and ongoing support is essential to maintain gains, the evidence is strong that ketamine can offer meaningful relief for those who’ve felt stuck in their depression.
Insurance coverage depends on the form of treatment. Spravato (esketamine) — the FDA-approved nasal spray for treatment-resistant depression — is often covered by insurances like the coverage you may have with your school or parents because it has a specific, recognized psychiatric indication. Coverage typically includes the medication, clinic administration, and monitoring, though patients may still have copays or deductibles. Ketamine in other forms — such as IV infusion, intramuscular injection, or oral lozenges — is used “off-label” for depression, meaning it’s not FDA-approved for that purpose. As a result, most insurers do not cover it, and treatment is usually paid for out of pocket. This difference is purely regulatory: the active drug in both Spravato and ketamine is chemically related, but only Spravato has undergone the approval process for psychiatric use. Some patients choose Spravato to access insurance benefits, while others prefer ketamine infusions for dosing flexibility or cost structure. At Lumin Health, we help people navigate both options so they can choose the path that best fits their clinical needs and financial circumstances.